Elekta AB header image

Elekta AB

EKTA B

Equity

ISIN SE0000163628 / Valor 613625

NASDAQ Nordic Exchange Stockholm, Equities (2024-09-18)
SEK 68.70+0.88%

Elekta AB
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Elekta AB is a global company that provides innovative solutions and AI-supported services to clinicians, enabling them to treat more patients with higher quality. The company's offerings are designed to improve patient outcomes and enhance the efficiency of healthcare providers. Elekta AB leverages its global network to deliver value-creating innovations in the field of medical technology, particularly in the areas of radiation therapy and radiosurgery. With a focus on cutting-edge technology and customer service, Elekta AB plays a crucial role in advancing healthcare worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Revenue Performance

In the fourth quarter of the fiscal year 2023/24, Elekta AB reported a net sales decrease of 2 percent, amounting to SEK 5,023 million compared to SEK 5,125 million in the same period the previous year. This represents a 2 percent decrease in constant exchange rates.

Order Intake

Elekta AB's gross order intake for the fourth quarter of 2023/24 increased by 1 percent to SEK 6,436 million from SEK 6,359 million in the previous year. However, this reflects a 1 percent decrease when adjusted for constant exchange rates.

Profitability

The adjusted operating income (Adjusted EBIT) for Elekta AB in the fourth quarter of 2023/24 was SEK 651 million, down from SEK 832 million in the same quarter of the previous year. This resulted in an adjusted EBIT margin of 13.0 percent, compared to 16.2 percent previously.

Earnings Per Share

Elekta AB reported earnings per share of SEK 1.08 for the fourth quarter of 2023/24, both before and after dilution. This is a decrease from SEK 1.43 per share in the same period of the previous year. Adjusted earnings per share were SEK 1.15, down from SEK 1.53.

Cash Flow

For the fourth quarter of 2023/24, Elekta AB's cash flow after continuous investments amounted to SEK 872 million, a significant decrease from SEK 1,574 million in the same quarter of the previous year.

Summarized from source with an LLMView Source

Key figures

-9.77%1Y
-34.3%3Y
-46.3%5Y

Performance

32.5%1Y
33.5%3Y
36.1%5Y

Volatility

Market cap

2496 M

Market cap (USD)

Daily traded volume (Shares)

1,210,422

Daily traded volume (Shares)

1 day high/low

68.8 / 67.65

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Kaken Seiyaku KK
Kaken Seiyaku KK Kaken Seiyaku KK Valor: 762167
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%JPY 3,915.00
Illumina Inc
Illumina Inc Illumina Inc Valor: 1111080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%USD 130.97
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.00%USD 88.53
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.48%USD 273.15
Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 72.46
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.12%USD 197.28
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%EUR 73.95
Almirall SA
Almirall SA Almirall SA Valor: 3180354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%EUR 8.51
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.65%EUR 45.26
KK Kose
KK Kose KK Kose Valor: 1017515
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%JPY 7,930.00